ATE244279T1 - Verfahren zur synthese von phthalocyaninverbindungen - Google Patents

Verfahren zur synthese von phthalocyaninverbindungen

Info

Publication number
ATE244279T1
ATE244279T1 AT97945416T AT97945416T ATE244279T1 AT E244279 T1 ATE244279 T1 AT E244279T1 AT 97945416 T AT97945416 T AT 97945416T AT 97945416 T AT97945416 T AT 97945416T AT E244279 T1 ATE244279 T1 AT E244279T1
Authority
AT
Austria
Prior art keywords
ligand
displacing
phthalocyanine
cl3ccoo
central silicon
Prior art date
Application number
AT97945416T
Other languages
English (en)
Inventor
Ying-Syi Li
Malcolm E Kenney
Original Assignee
Univ Cleveland Hospitals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Cleveland Hospitals filed Critical Univ Cleveland Hospitals
Application granted granted Critical
Publication of ATE244279T1 publication Critical patent/ATE244279T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B47/00Porphines; Azaporphines
    • C09B47/04Phthalocyanines abbreviation: Pc
    • C09B47/30Metal-free phthalocyanines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B47/00Porphines; Azaporphines
    • C09B47/04Phthalocyanines abbreviation: Pc
    • C09B47/08Preparation from other phthalocyanine compounds, e.g. cobaltphthalocyanineamine complex

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT97945416T 1996-10-01 1997-09-30 Verfahren zur synthese von phthalocyaninverbindungen ATE244279T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/724,347 US5763602A (en) 1996-10-01 1996-10-01 Methods of syntheses of phthalocyanine compounds
PCT/US1997/017690 WO1998014521A1 (en) 1996-10-01 1997-09-30 Novel methods of syntheses of phthalocyanine compounds

Publications (1)

Publication Number Publication Date
ATE244279T1 true ATE244279T1 (de) 2003-07-15

Family

ID=24910068

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97945416T ATE244279T1 (de) 1996-10-01 1997-09-30 Verfahren zur synthese von phthalocyaninverbindungen

Country Status (9)

Country Link
US (1) US5763602A (de)
EP (1) EP1023399B1 (de)
JP (1) JP2001506584A (de)
KR (1) KR20000036186A (de)
AT (1) ATE244279T1 (de)
AU (1) AU4662697A (de)
CA (1) CA2267389A1 (de)
DE (1) DE69723322T2 (de)
WO (1) WO1998014521A1 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6322980B1 (en) * 1999-04-30 2001-11-27 Aclara Biosciences, Inc. Single nucleotide detection using degradation of a fluorescent sequence
US7771929B2 (en) * 2000-04-28 2010-08-10 Monogram Biosciences, Inc. Tag library compounds, compositions, kits and methods of use
US20030207300A1 (en) * 2000-04-28 2003-11-06 Matray Tracy J. Multiplex analytical platform using molecular tags
US7537938B2 (en) * 2000-04-28 2009-05-26 Monogram Biosciences, Inc. Biomarker detection in circulating cells
US7160735B2 (en) * 2000-04-28 2007-01-09 Monogram Biosciences, Inc. Tagged microparticle compositions and methods
AU2002305658A1 (en) 2001-05-21 2002-12-03 Aclara Biosciences, Inc. Analyzing phosphorylated proteins
JP2005505749A (ja) 2001-05-21 2005-02-24 アクララ バイオサイエンシーズ, インコーポレイテッド タンパク質を分析するための方法および組成物
WO2002096913A1 (en) * 2001-05-25 2002-12-05 Gentian As Substituted di(hydroxy/alkoxy)silicon phthalocyanines and their uses
US7358052B2 (en) * 2001-05-26 2008-04-15 Monogram Biosciences, Inc. Catalytic amplification of multiplexed assay signals
US20040229380A1 (en) * 2002-05-21 2004-11-18 Po-Ying Chan-Hui ErbB heterodimers as biomarkers
US7105308B2 (en) 2002-07-25 2006-09-12 Monogram Biosciences, Inc. Detecting receptor oligomerization
US20040091850A1 (en) * 2002-11-08 2004-05-13 Travis Boone Single cell analysis of membrane molecules
US7402398B2 (en) * 2003-07-17 2008-07-22 Monogram Biosciences, Inc. Measuring receptor homodimerization
CA2535510C (en) * 2003-08-11 2013-10-15 Monogram Biosciences, Inc. Detecting and profiling molecular complexes
CA2543830A1 (en) * 2003-10-27 2005-05-19 Monogram Biosciences, Inc. Detecting human anti-therapeutic antibodies
US7939267B2 (en) * 2004-11-04 2011-05-10 Laboratory Corporation Of America Holdings Detection of activation of endothelial cells as surrogate marker for angiogenesis
WO2008098100A2 (en) * 2007-02-07 2008-08-14 Perscitus Biosciences, Llc Detection of molecule proximity
CA2711843C (en) * 2007-12-20 2018-11-13 Laboratory Corporation Of America Holdings Her-2 diagnostic methods
US8470542B2 (en) * 2008-12-01 2013-06-25 Laboratory Corporation Of America Holdings Methods and assays for measuring p95 and/or p95 complexes in a sample and antibodies specific for p95
SG172983A1 (en) 2009-01-15 2011-08-29 Lab Corp America Holdings Methods of determining patient response by measurement of her-3
CA2753269C (en) 2009-02-20 2017-04-25 Perkinelmer Biosignal, Inc. Multiplex assay methods and compositions
US8440641B2 (en) * 2009-03-20 2013-05-14 Case Western Reserve University Phthalocyanine salt formulations
JP6468838B2 (ja) 2011-05-19 2019-02-13 ラボラトリー コーポレイション オブ アメリカ ホールディングス 癌患者の生存可能性を決定するためおよび癌患者における転移可能性を予測するための方法
WO2013020067A1 (en) 2011-08-03 2013-02-07 Sun Chemical Corporation Phthalocyanine synthesis
KR101471613B1 (ko) * 2013-02-07 2014-12-12 광주과학기술원 고분자 태양전지 및 이의 제조방법
CN105264382A (zh) 2013-04-05 2016-01-20 美国控股实验室公司 基于检测her3活化辅助癌症的诊断、预后和治疗的系统和方法
JP2019515252A (ja) 2016-03-15 2019-06-06 ラボラトリー コーポレイション オブ アメリカ ホールディングス 細胞間のタンパク質相互作用を評価する方法
PT3482210T (pt) 2016-07-06 2021-07-28 Prothena Biosciences Ltd Ensaio para detetar alfa-sinucleína total e fosforilada s129
CA3046489A1 (en) 2016-12-07 2018-06-14 Progenity Inc. Gastrointestinal tract detection methods, devices and systems
KR102616436B1 (ko) 2016-12-14 2023-12-27 비오라 쎄라퓨틱스, 인크. Tnf 저해제로의 위장관 질환의 치료
EP3554344A1 (de) 2016-12-14 2019-10-23 Progenity, Inc. Behandlung der erkrankung des gastrointestinaltraktes mit einem tlr-modulator
WO2018112232A1 (en) 2016-12-14 2018-06-21 Progenity Inc. Treatment of a disease of the gastrointestinal tract with an il-12/il-23 inhibitor released using an ingestible device
TW201834690A (zh) 2016-12-14 2018-10-01 美商寶珍那提公司 以免疫抑制劑治療胃腸道疾病
WO2018112237A1 (en) 2016-12-14 2018-06-21 Progenity Inc. Treatment of a disease of the gastrointestinal tract with an il-6r inhibitor
EP3554541B1 (de) 2016-12-14 2023-06-07 Biora Therapeutics, Inc. Behandlung einer erkrankung des gastrointestinaltraktes mit einem chemokin/chemokin-rezeptor-inhibitor
EP3554345A1 (de) 2016-12-14 2019-10-23 Progenity, Inc. Behandlung von erkrankungen des gastrointestinaltraktes mit einem smad7-inhibitor
AU2017378398B2 (en) 2016-12-14 2023-02-02 Bt Bidco, Inc. Treatment of a disease of the gastrointestinal tract with a JAK inhibitor and devices
CA3045931A1 (en) 2016-12-14 2018-06-21 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with an integrin inhibitor
EP3554343A1 (de) 2016-12-14 2019-10-23 Progenity, Inc. Behandlung einer erkrankung des gastrointestinaltraktes mit einem il-1-inhibitor
CA3054156A1 (en) 2017-03-30 2018-10-04 Progenity Inc. Treatment of a disease of the gastrointestinal tract with il-10 or an il-10 agonist
WO2018183932A1 (en) 2017-03-30 2018-10-04 Progenity Inc. Treatment of a disease of the gastrointestinal tract with a il-13 inhibitor
CA3054159A1 (en) 2017-03-30 2018-10-04 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with a chst15 inhibitor
US20210138213A1 (en) 2017-03-30 2021-05-13 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with an immune modulatory agent released using an ingestible device
AU2018244922A1 (en) 2017-03-30 2019-09-12 Biora Therapeutics, Inc. Treatment of a disease of the gastrointestinal tract with live biotherapeutics
US20200306516A1 (en) 2017-08-14 2020-10-01 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with glatiramer or a pharmaceutically acceptable salt thereof
CA3102255A1 (en) 2018-06-01 2019-12-05 Progenity, Inc. Devices and systems for gastrointestinal microbiome detection and manipulation
WO2021207691A1 (en) * 2020-04-10 2021-10-14 Rakuten Medical, Inc. Phthalocyanine dye compounds, conjugates and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4927735A (en) * 1987-01-07 1990-05-22 Hitachi Chemical Company, Ltd. Novel naphthalocyanine dye, method for preparing the same, and optical information recording medium employing the same
ATE206395T1 (de) * 1990-05-15 2001-10-15 Hyperion Inc Fluoreszierende porphyrin- und fluoreszierende phthalocyanin-polyethylenglykol-, polyol- und saccharidderivate als fluoreszierende sonden
US5166197A (en) * 1990-07-17 1992-11-24 Kenney Malcolm E Phthalocyanine photosensitizers for photodynamic therapy
US5484778C1 (en) * 1990-07-17 2001-05-08 Univ Cleveland Hospitals Phthalocynine photosensitizers for photodynamic therapy and methods for their use
TW235298B (de) * 1992-02-27 1994-12-01 Ciba Geigy

Also Published As

Publication number Publication date
DE69723322T2 (de) 2004-05-27
KR20000036186A (ko) 2000-06-26
AU4662697A (en) 1998-04-24
EP1023399A4 (de) 2002-02-27
WO1998014521A1 (en) 1998-04-09
JP2001506584A (ja) 2001-05-22
CA2267389A1 (en) 1998-04-09
DE69723322D1 (de) 2003-08-07
US5763602A (en) 1998-06-09
EP1023399B1 (de) 2003-07-02
EP1023399A1 (de) 2000-08-02

Similar Documents

Publication Publication Date Title
ATE244279T1 (de) Verfahren zur synthese von phthalocyaninverbindungen
Brookhart et al. Enantioselective cyclopropane synthesis using the chiral carbene complexes (SFeSC)-and (RFeSC)-(C5H5)(CO)(Ph2R* P) Fe: CHCH3+ (R*=(S)-2-methylbutyl). Role of metal vs. ligand chirality in the optical induction
DE59108707D1 (de) Verfahren zur Herstellung von Oxetanonen
DE60005143D1 (de) Herstellung von iodixanol
ATE205824T1 (de) Verfahren zur herstellung von citalopram
DE69103265D1 (de) Verfahren zur stereoselektiven herstellung von phenylisoserinderivaten.
Moody et al. Stereospecific synthesis of 4-alkylglutamates and 4-alkylprolines
ATE264268T1 (de) Verfahren zur herstellung von zsm-5 und zsm-11
ATE132487T1 (de) Verfahren zur herstellung von substituierten piperidinen
ATE174601T1 (de) Verfahren zur herstellung von bisnoraldehyden aus bisnoralkohol
ATE160351T1 (de) Verfahren zur herstellung von 7-trialkylsilyl baccatin iii
ATE359272T1 (de) Verfahren zur herstellung von 3-hydroxy-n-1,6-
ATE270301T1 (de) Verfahren zur herstellung von modifizierten p- chiralen nucleotid-analoga
Nishide et al. One‐Step Stereocontrol of Three Contiguous Stereogenic Centers in Acyclic Systems: The Tuning Effect of an Additive in a Tandem Asymmetric Michael Addition and Meerwein–Ponndorf–Verley Reduction
DE69820481D1 (de) Verfahren zur herstellung von cholecalciferol-derivaten und zwischenverbindungen
DE60015563D1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
RU2219161C2 (ru) Способ синтеза таксанов
Soucy et al. Remarkable diastereoselectivity in the addition of allylic and unsaturated diorganozinc reagents to β-(N, N-dialkylamino)-aldehydes
RU94046247A (ru) Способ получения практически беспыльного гранулята из тетрагидро-3,5-диметил-1,3,5-тиадиазин-2-тиона
ATE299851T1 (de) Verfahren zur herstellung von zwischenprodukten
DE59502606D1 (de) Verfahren zur herstellung von selegilin
ATE159517T1 (de) Verfahren zur herstellung von n-carbonylarylimine als zwischenprodukte in der synthese von therapeutisch aktiven taxol-derivaten
DE60142962D1 (de) Verfahren zur herstellung von pestiziden verbindungen
Liu et al. A convenient synthesis of N-fluorenylmethoxycarbonyl-N-methyl-L-cysteine derivatives [Fmoc, Me-Cys (R)-OH]
DE69816445D1 (de) Verfahren zur herstellung von 2-trifluormethoxynalin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties